Immunogenomics operates a CLIA certified facility and collaborates with leading platform providers including ThermoFisher, Illumina, Fluidigm, Agena, BioRad and other platforms to secure early access to advanced technologies. Our team is validating a comprehensive menu of high parameter Immuno oncology expression profiling assays to explore tumor immunobiology and identify new biomarkers and pharmacogenomics.